Detection and Characterization of Viral Pathogens with Microfluidics-based Genomic Analysis

30 April 2020

Speaker: Ganesh Babu, PhD, Field Applications Scientist, Fluidigm

In a short period of time, a novel coronavirus (SARS-CoV-2) has impacted our lives, society and health care infrastructure. In today's online seminar, we will provide examples of how Fluidigm products are supporting global laboratory efforts in response to COVID-19 to address critical needs for testing and clinical research by delivering:

• Versatile automated microfluidic systems that support multiple biomarker types (DNA, RNA and protein)
• Scalable throughput that enables the testing of more than 6,000 samples per day, with multiple targets of interest per sample
• Flexible panel designs that enable users to easily add, remove or change assays without changing technologies
• Cost-efficient workflows that minimize reagent consumption using microfluidics technology